This baseline testing provides concrete data about which nutrients you might genuinely need rather than guessing based on symptoms alone
Tymoczko, G.J
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease, counteracts NSAID-induced intestinal damage
Liu X, Zeng Z, Zhao L, Chen P, Xiao W
The consequences of the cardiovascular disease-related reductions in CBF include accelerated reduction in frontal, parietal, and temporal grey matter volumes (Anazodo et al., 2013), greater white matter hyperintensity burden (Moroni et al., 2018), cognitive deficits (Jiang et al., 2023), and increased risk of ADRD (Brain et al., 2023)
It binds to harmful toxins, heavy metals, and environmental pollutants, transforming them into water-soluble compounds that the body can safely excrete